Will Johnson & Johnson Do a Stock Split in 2018?
Healthcare has been an exciting industry lately, and Johnson & Johnson (NYSE: JNJ) casts a wide net over the sector. The company not only sells well-known consumer brands like Tylenol and Johnson's Baby Shampoo but also has extensive operations in pharmaceutical development and medical device manufacturing. Long-time shareholders have seen strong returns, and a big portion of their gains has been due to the dividend payments they've received. Yet despite a rising share price, Johnson & Johnson hasn't done a stock split in 16 years. Let's take a closer look at Johnson & Johnson and whether now could be the time to change that pattern.
Johnson & Johnson definitely hasn't avoided splits throughout its history. On many occasions over the years, the healthcare conglomerate has made moves to split its shares.
Date of Split
Source: Fool.com
Johnson & Johnson Aktie
Hohe Buy- und niedrige Sell-Zahlen bei Johnson & Johnson zeigen ein stark positives Sentiment.
Für Johnson & Johnson ergibt sich mit einem Kursziel von 194 € eine mögliche Steigerung von über 20% gegenüber 148.74 €.
